Veterans and Americans struggling with serious mental illness deserve new hope and better treatment options.

Department of Health and Human Services on X official account2026-11-12

Veterans and Americans struggling with serious mental illness deserve new hope and better treatment options. HHS and @ARPA_H are investing up to $4.9M to advance ibogaine research for PTSD, alongside a new $20M funding opportunity to study rapid-acting treatments like ketamine, esketamine, and psilocybin.

Posted on X 2026-11-12 by @HHSGov · View on X →

An image attached to the post

The image reads:

PRESS RELEASE HHS Announces Awards to Advance Development of Ibogaine for PTSD & New Funding to Advance Rapid-acting Psychotropics HHS MAKE AMERICA HEALTHY AGAIN

Open the full analysis →

What the model flagged

Analyzed 2026-11-12 17:31 UTC.

Findings may include language that is quoted rather than the speaker's own, and the model over-reads ceremonial language (tributes, anniversaries) as persuasion. Check each finding against the original.

No techniques were flagged.

Claims checked

A verdict that says a claim is wrong or misleading is shown as such only when it cites an established fact-checker or a primary source that is not Department of Health and Human Services on X's own, and its confidence is not low. Otherwise the claim is shown as unverifiable, with the reason and the source we found.

“HHS and @ARPA_H are investing up to $4.9M to advance ibogaine research for PTSD”
The sources we found don't settle it: The search found no source that addresses this claim. Verdict right?

“a new $20M funding opportunity to study rapid-acting treatments like ketamine, esketamine, and psilocybin”
The sources we found don't settle it: The search found no source that addresses this claim. Verdict right?

Full analysis, paragraph by paragraph

The complete text as analyzed. Highlighted paragraphs are where the model found a technique.

Veterans and Americans struggling with serious mental illness deserve new hope and better treatment options. HHS and @ARPA_H are investing up to $4.9M to advance ibogaine research for PTSD, alongside a new $20M funding opportunity to study rapid-acting treatments like ketamine, esketamine, and psilocybin.

PRESS RELEASE HHS Announces Awards to Advance Development of Ibogaine for PTSD & New Funding to Advance Rapid-acting Psychotropics HHS MAKE AMERICA HEALTHY AGAIN

Analyzed automatically with Semblen's fine-tuned model. These are rhetorical techniques, not political tilt — finding one is not a claim that the statement is false. How items are chosen →

Try Pro free for 7 days, no card. Claim checks with their sources, and an email when the stories you follow change.